Background {#Sec1}
==========

Animal development is strictly controlled by cell type- and stage-specific gene expression programs that are primarily regulated by transcription factors \[[@CR1], [@CR2]\]. On the other hand, epigenetic regulators play critical roles in maintenance of cellular memory once the cell identity is established \[[@CR3]\]. DNA methylation is a major epigenetic mark regulating gene repression, genomic imprinting, and X chromosome inactivation \[[@CR4], [@CR5]\]. DNA methyltransferase 1 (DNMT1) recognizes hemi-methylated CpGs and methylates CpGs on the newly synthesized DNA during genome replication. This ensures the heritability of the methylation patterns in each cell lineage \[[@CR6]\]. Two other methyltransferases, DNMT3a and DNMT3b, can conduct de novo DNA methylation. DNA methylation is essential for animal development, as mice deficient in *Dnmt1* or *Dnmt3* are embryonically lethal \[[@CR7]--[@CR9]\]. In addition to DNA methylation, chromatin modifications also play crucial roles in gene regulation and development \[[@CR10]\]. For example, histone H3K4me3 is a mark that is associated with gene activity \[[@CR11]\]. On the other hand, H3K27me3 is a repressive histone mark that is strongly linked to gene silencing \[[@CR12]\]. Disruption of the H3K4me3 methyltransferases, such as mixed-lineage leukemia 1 (MLL1) and MLL2, or the Polycomb repressive complex 2 (PRC2), which is responsible for H3K27 methylation, frequently leads to embryonic lethality \[[@CR10], [@CR13]\].

Given the profound impact on animal development by ablation of DNMTs, DNA methylation has long been considered as a major repression mechanism of tissue-specific genes \[[@CR6]\]. However, other studies as well as ours revealed that, upon cell differentiation, DNA methylation appears to be regulated only at a small number of promoters, whereas it is much more dynamic at enhancers \[[@CR14]--[@CR16]\]. DNA methylation is constantly absent at many promoters of key regulators for embryonic development regardless of their transcription activities. These promoters frequently show unusually large hypomethylated regions extending well beyond their proximal promoters, a pattern that we termed DNA methylation valley (DMV) \[[@CR14]\]. Similar patterns were also identified by other groups as "broad non-methylated islands (NMIs)" \[[@CR17]\] or "DNA methylation canyons" \[[@CR18]\]. Interestingly, DMVs often include both CpG islands (CGIs), which are known to be constantly hypomethylated \[[@CR19]\], and non-CGI regions. How DMVs are regulated and maintained as hypomethylated, and why they occur predominantly at key transcription factor genes remain elusive.

Notably, a large portion of DMVs are marked by H3K27me3 \[[@CR14], [@CR17], [@CR18]\], which is consistent with the notion that developmental gene promoters are preferential targets of Polycomb \[[@CR20]\]. It is believed that the repression mediated by H3K27me3 is easier to reverse, thus retaining developmental plasticity. DNA methylation, on the other hand, is considered as a more stable repression mechanism \[[@CR6]\]. The fact that DMVs are strongly marked by H3K27me3 raises an interesting possibility that these two mechanisms may antagonize each other. Indeed, it has been shown that PRC2 binds poorly to nucleosomes with methylated DNA \[[@CR21], [@CR22]\]. As a possible consequence, depletion of DNA methylation leads to "spreading" of H3K27me3 into non-target regions and a decrease of H3K27me3 at Polycomb targets \[[@CR23], [@CR24]\]. Such spreading of H3K27me3 can repress retrotransposon activities in the absence of DNA methylation \[[@CR25]\]. A single molecular analysis also revealed that H3K27me3 and DNA methylation seldom co-exist \[[@CR26]\]. However, other studies also suggest that DNA methylation and H3K27me3 can co-occur in a genomic region-dependent manner, particularly in regions with low CG density \[[@CR23], [@CR27]\]. On the other hand, the effects of Polycomb and H3K27me3 on DNA methylation are less clear. Previously, it was shown that the depletion of H3K27me3 only alters the DNA methylation at a limited number of promoters \[[@CR28]\]. However, this change of DNA methylation was determined using methylated DNA immunoprecipitation (MeDIP), a relatively low-resolution approach \[[@CR29]\]. In this study, we sought to determine the molecular mechanisms underlying the regulation of hypomethylation in DMVs. Our results showed that DMVs are strongly enriched for transcription factor binding sites and are highly conserved in sequences. Furthermore, we found that Polycomb is required for the maintenance of DMV hypomethylation and regulates DNA methylation, likely through ten-eleven translocation proteins (TETs). We propose that Polycomb may promote hypomethylation of DMVs at key transcription factor genes and contribute to the fidelity of regulatory elements.

Results {#Sec2}
=======

DMVs are hypomethylated throughout development and are conserved across vertebrates {#Sec3}
-----------------------------------------------------------------------------------

Previously, DMVs or DNA methylation canyons were identified in a number of human and mouse cell types \[[@CR14], [@CR18]\]. We aimed to determine if DMVs are also broadly present in different species and across developmental stages. By examining a panel of 16 mouse tissue methylomes \[[@CR15]\], we found widespread DMVs in these tissues using a method described previously \[[@CR14]\] ([Methods](#Sec11){ref-type="sec"}) (Fig. [1a](#Fig1){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S1A), with numbers ranging from 696 to 1454 (Additional file [1](#MOESM1){ref-type="media"}: Figure S1B, Additional file [2](#MOESM2){ref-type="media"}: Table S1). To examine if DMVs are present throughout the mouse developmental cycle, we examined DNA methylome data in primordial germ cells (PGCs) (E10.5, E13.5, and E16.5) \[[@CR30]\], spermatozoa, oocytes, and early embryos \[[@CR31]\]. We found that DMVs (pooled from all mouse tissues) are largely hypomethylated across developmental stages (Fig. [1b](#Fig1){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S1C). It is worth noting that we recently also determined DNA methylomes in mouse postimplantation lineages and found that a portion of DMVs are relatively hypermethylated in E5.5 epiblast and extraembryonic tissues, although their overall levels of DNA methylation are still low compared to the genome average \[[@CR32]\]. Finally, we wondered if DMVs are conserved in other vertebrate species. By investigating the methylomes from zebrafish \[[@CR33]\], we also identified DMVs with associated genes strongly enriched for developmental genes and genes coding transcription factors similar to those of human and mouse (Fig. [1a, c](#Fig1){ref-type="fig"}, Additional file [3](#MOESM3){ref-type="media"}: Table S2). Taken together, these data suggest that DMVs are hypomethylated throughout developmental periods and are highly conserved in vertebrates.Fig. 1A global survey of DNA methylation valleys (DMVs) in various vertebrates. **a** University of California, Santa Cruz (UCSC) Genome Browser snapshots of various methylomes for a DMV near *Foxa1* in three vertebrates: mouse \[[@CR15]\], human \[[@CR14]\], and zebrafish \[[@CR33]\]. *H1* human embryonic stem cell (hESC), *ME* mesendoderm, *NPC* neural progenitor cell, *TBL* trophoblast-like cell, *MSC* mesenchymal stem cell, *IMR90*, human fetal lung fibroblast cell line. **b** UCSC Genome Browser snapshot of a DMV near *Sox1* at different stages of mouse development. **c** Gene ontology analysis of DMV genes in different vertebrates (human, mouse, and zebrafish). Examples of transcription factors shared among all three vertebrates are listed below

DMVs are hotspots of TF binding sites {#Sec4}
-------------------------------------

An intriguing question that remains is why developmental genes require large hypomethylated domains at promoters. We reasoned that these key regulator genes are in turn strictly controlled by other transcription regulators. Using human methylomes we reported previously \[[@CR14]\] and transcription factor chromatin immunoprecipitation sequencing (ChIP-seq) datasets from the Encyclopedia of DNA Elements (ENCODE) \[[@CR34]--[@CR36]\], we found that transcription factor binding sites are densely present in DMVs and that the binding frequencies decrease sharply outside of DMVs (Fig. [2a, b](#Fig2){ref-type="fig"}). Interestingly, DMVs overall contain even more transcription factor binding sites compared to super-enhancers \[[@CR37]\] and simple CGI clusters \[[@CR14]\]. This is contributed by both CGIs and, to a lesser extent, non-CGI regions of DMVs (Additional file [1](#MOESM1){ref-type="media"}: Figure S2A). The ranges of transcription factor binding sites are much broader for the promoters of DMV genes than for non-DMV genes (Fig. [2c](#Fig2){ref-type="fig"}). Such results were also similarly observed when using a dataset of mouse transcription factor binding sites determined by ChIP-seq \[[@CR38]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S2B). Consistent with the notion that transcription factor bindings are associated with nucleosome depletion \[[@CR39]\], we found that DMV regions are occupied by fewer nucleosomes than their surrounding regions (Additional file [1](#MOESM1){ref-type="media"}: Figure S2C). Interestingly, by searching for transcription factor motifs present in DMVs, we found that CGI and non-CGI regions in DMVs are enriched for motifs for many homeobox transcription factors such as NKX, LHX, HOX, and OCT factors and other developmental regulators such as GATA factors (Fig. [2d](#Fig2){ref-type="fig"}). As a control, this was not observed for all promoters in the genome (Fig. [2d](#Fig2){ref-type="fig"}). Hence, these data indicate that DMVs are hotspots of regulatory elements for key developmental genes.Fig. 2DMVs are hotspots of transcription factor (*TF*) binding sites. **a** The average distribution of TF binding sites (per kb) around human DMVs or CpG island (*CGI*) clusters based on ChIP-seq data from ENCODE \[[@CR35]\]. Random sequences with the same lengths as DMVs in the genome were used as a control. CGI clusters were defined as described previously \[[@CR14]\]. Super-enhancers were defined in human embryonic stem cells as previously described \[[@CR37]\]. **b** UCSC Genome Browser snapshots of DNA methylomes for sperm \[[@CR85]\] and various cell types \[[@CR14]\] and TF binding density \[[@CR35]\] in human DMVs near *Foxa1* and *Gata2*. **c** The average distribution of TF bindings around transcription start sites (*TSSs*) in human \[[@CR35]\] for promoters in DMVs or other promoters. **d** TF motif analysis of different regions in the human genome CGI in DMVs, non-CGI in DMVs, CGI in all promoters, and non-CGI in all promoters). The scale of the *circles* represents motif enrichment. *Red* represents homeobox TFs. **e** Venn diagram showing the overlap between DMVs and hyper-conserved CpG island domains (HCGDs) \[[@CR41]\] in human. **f** Boxplot showing deamination rates \[[@CR42]\] for human CGIs inside or outside DMVs classified based on their CG densities

The high density of TF binding in DMVs indicates that developmental genes may require complex regulation that involves a large set of regulatory factors. It is tempting to speculate that the constant hypomethylation of DMVs may be crucial for maintaining the plasticity of gene expression by avoiding DNA methylation at regulatory regions. On the other hand, methylcytosines are known as hotspots of mutations, as DNA methylation can lead to deamination of Cs and subsequent conversion to Ts \[[@CR19]\]. Recent efforts of large-scale cancer genome sequencing also confirmed that the most prominent mutations in cancer are C-to-T mutations in the CpG context \[[@CR40]\]. Therefore, the presence of DMVs may help decrease the risks of spontaneous deamination mutations. Indeed, a previous study identified 190 hyper-conserved CpG island domains (HCGDs) in the human genomes \[[@CR41]\]. Strikingly, we found that 146 out of 190 (77%) HCGDs are present in DMVs \[[@CR14]\] (Fig. [2e](#Fig2){ref-type="fig"}). In fact, DMVs are more conserved than CGI clusters \[[@CR14]\] and super-enhancers \[[@CR37]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S2D). By examining a published dataset of sequence deamination rate in the human genome derived from multiple species sequence comparison \[[@CR42]\], we indeed observed low rates of deamination in DMV regions compared to their surrounding regions (Additional file [1](#MOESM1){ref-type="media"}: Figure S2E). This is not simply due to CG density, as both CGIs and non-CGIs in DMVs show lower deamination rates than loci outside of DMVs with similar CG density levels (Fig. [2f](#Fig2){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S2F). Therefore, these data raise a possibility that the hypomethylation of DMVs may help ensure expression plasticity and sequence fidelity at these regulatory elements.

Analyses of DNA methylation and gene expression revealed dynamic regulation of DMVs {#Sec5}
-----------------------------------------------------------------------------------

Intriguingly, while the majority of human DMVs remain hypomethylated in various cell types, we also found that a number of DMVs clearly show variable DNA methylation across mouse tissues (Fig. [3a](#Fig3){ref-type="fig"}, right two panels). Interestingly, using hierarchical clustering, we showed that the DNA methylation levels in mouse DMVs could correctly group tissues with similar origins (Additional file [1](#MOESM1){ref-type="media"}: Figure S3A), suggesting that DNA methylation variations in DMVs are linked to lineage identities. We further classified all mouse tissue DMVs into three groups (Fig. [3a](#Fig3){ref-type="fig"}, [b](#Fig3){ref-type="fig"}) ([Methods](#Sec11){ref-type="sec"}). Group I (*n* = 1580) shows constant DNA methylation levels in DMVs across all tissues regardless of the expression levels of their associated genes. Group II (*n* = 132) shows dynamic DNA methylation levels across different tissues, demonstrating lower DNA methylation when associated genes are activated. This is consistent with the notion that transcription is generally associated with DNA hypomethylation near promoters \[[@CR6]\]. The third group of DMVs (*n* = 34) also shows dynamic DNA methylation levels across different tissues. However, to our surprise, these DMVs demonstrated higher DNA methylation when the associated genes are expressed. Notably, this increased DNA methylation is largely limited to non-CGIs in DMVs and loci outside of promoters (Fig. [3a](#Fig3){ref-type="fig"}). To characterize these hypermethylated regions, we took advantage of a study that identified tissue-specific differentially methylated regions (tsDMRs) across these mouse tissues \[[@CR15]\]. Indeed, we found that tsDMRs in these DMVs preferentially reside in low-CG regions (Fig. [3c](#Fig3){ref-type="fig"}). By examining a panel of histone modification ChIP-seq data in mouse tissues \[[@CR43]\], we found that groups I and III DMVs are preferentially enriched for high CpGs (Additional file [1](#MOESM1){ref-type="media"}: Figure S3B) and H3K27me3 (Fig. [3d](#Fig3){ref-type="fig"}), both of which are known to occupy developmental regulator promoters \[[@CR12], [@CR13]\]. Indeed, these two groups, but not group II, are enriched for transcription factor genes (Additional file [1](#MOESM1){ref-type="media"}: Figure S3C). Notably, group III contains much larger DMVs compared to the other two groups (Additional file [1](#MOESM1){ref-type="media"}: Figure S3B), which may contribute to its dynamic nature. As a comparison, group I DMVs are smaller, and their constant hypomethylation may result from strict protection mechanisms near proximal promoters including those through CpG islands \[[@CR19]\]. By contrast, group II DMV regions show tissue-specific H3K4me3 peaks and clustered histone H3K27ac peaks (Fig. [3a](#Fig3){ref-type="fig"}), a feature that resembles that of super-enhancers \[[@CR44]\]. Indeed, by identifying super-enhancers in various tissues using a previously described method \[[@CR37]\], we found that group II DMVs are significantly enriched for super-enhancers (27%) compared to groups I and III (\~5% and 14%, respectively) (Fig. [3e](#Fig3){ref-type="fig"}). This is also consistent with the previous observation that enhancers are generally hypomethylated \[[@CR16]\]. In sum, these data revealed that a subset of DMVs are dynamically regulated. It is intriguing why DMVs marked by H3K27me3 are preferentially hypomethylated including those in groups I and III. Thus, we mainly focused on these DMVs in the subsequent analyses.Fig. 3Identification of three groups of DMVs. **a** UCSC Genome Browser snapshots of DNA methylomes, histone modifications, and RNA levels near group I DMVs (*Srsf2*, *Six1*), a group II DMV (*Gpr85*), and a group III DMV (*Pax6*) in mouse tissues. Regions with dynamic DNA methylation are shaded. **b** Boxplot showing the correlation coefficients between DNA methylation and gene expression for three groups of DMVs in mouse tissues. **c** Boxplot showing the CG density for DMVs or tissue-specific differentially methylated regions (tsDMR) within DMVs. **d** The chromatin state (presence of H3K4me3 and/or H3K27me3) is shown for different groups of DMVs. **e** Percentages of DMVs with super-enhancers are shown as bar graphs for different groups of DMVs

Polycomb is required for maintenance of hypomethylation in DMVs {#Sec6}
---------------------------------------------------------------

We sought to determine what causes the hypomethylation of H3K27me3-marked DMVs. Notably, as increased DNA methylation in DMVs is accompanied by the loss of H3K27me3 upon gene activation for group III DMVs (Fig. [3a](#Fig3){ref-type="fig"}), we reasoned that the Polycomb protein complex may be important for keeping DNA methylation-free at these DMVs. Intriguingly, we found that the binding of the Polycomb proteins (EED, enhancer of zeste homolog 2 (EZH2) \[[@CR45]\], RING1B \[[@CR45]\]) is more correlated with hypomethylation in DMVs than H3K27me3, as regions marked only by H3K27me3 but not Polycomb do not show DNA hypomethylation (Fig. [4a](#Fig4){ref-type="fig"}, [b](#Fig4){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S4A). Therefore, these data indicate that the hypomethylation of DMVs may be related to Polycomb instead of H3K27me3. To test the role of Polycomb in DMV hypomethylation, we investigated DNA methylation using MethylC-sequencing (MethylC-seq) in wild-type (WT) mouse embryonic stem cells (mESCs) \[[@CR14]\] and mESCs deficient in *Eed*, a component of the PRC2 complex \[[@CR46]\]. The loss of *Eed* was validated by probing H3K27me3 using western blots (Additional file [1](#MOESM1){ref-type="media"}: Figure S4B) and ChIP-seq (Fig. [4c](#Fig4){ref-type="fig"}). Strikingly, we observed widespread elevation of DNA methylation in DMVs in *Eed* ^-/-^ cells (Fig. [4c](#Fig4){ref-type="fig"}). We also confirmed that no significant expression change of DNMTs was observed in these cells (data not shown). These observations were further verified using mESCs deficient in *Ezh2*, another key component of Polycomb (Fig. [4c](#Fig4){ref-type="fig"}), and several other WT mESC methylomes to avoid cell line methylation variations (Additional file [1](#MOESM1){ref-type="media"}: Figure S4C). Such DNA methylation increase is less evident for non-Polycomb-targeted DMVs (Fig. [4d](#Fig4){ref-type="fig"}). Importantly, our analyses showed that approximately 60% of group III DMVs identified in mouse tissues show hypermethylation in *Eed* ^-/-^ mESCs (compared to 18% and 10% of groups I and II, respectively), suggesting a similar function of PRC2 in maintaining hypomethylation in tissues and mESCs. Notably, regions with elevated methylation in the *Eed*-deficient cells are again limited to non-CGI regions in DMVs (Fig. [4e](#Fig4){ref-type="fig"}). In regions with lowest CG density, DNA methylation can increase more than 0.3 (Fig. [4f](#Fig4){ref-type="fig"}). Notably, CGI regions are maintained DNA methylation-free by several mechanisms including H3K4me3, a histone mark that is mutually exclusive with DNA methylation \[[@CR19]\]. Therefore, these results suggest that Polycomb and other factors at CGIs collaboratively maintain the hypomethylated state of DMVs.Fig. 4Polycomb is required for maintenance of hypomethylation in DMVs. **a** Heatmaps representing the corresponding level of DNA methylation and binding intensity of EED, EZH2, and RING1B \[[@CR45]\] for large K27me3 peaks (\> 5 kb, the minimal length of DMVs). Peaks were sorted by the DNA methylation levels in DMVs. An analysis of all H3K27me3 peaks yielded similar results (data not shown). **b** The epigenetic landscape is shown for Polycomb-bound DMV gene *Foxa1* and H3K27me3-marked non-DMV gene *Lyrm9*. Regions with elevated DNA methylation in *Eed* ^-/-^ mESCs are *shaded*. **c** Heatmaps representing the level of DNA methylation, H3K27me3, H3K27ac, H3K4me3, H3K36me3 within DMVs, and RNA level for DMV genes in WT and *Eed* ^-/-^ mESCs. DNA methylation level in *Ezh2* ^-/-^ mESCs is also shown. All DMVs are normalized to the same length. Levels of chromatin marks were Z-score-normalized. Fragments per kilobase per million mapped reads (*FPKMs*) of RNA level for WT and *Eed* ^-/-^ mESCs were quantile-normalized and log-transformed. EED-bound DMVs were defined as Polycomb DMVs. **d** Boxplots showing the DNA methylation level of Polycomb DMVs and other DMVs in WT and *Eed* ^-/-^ mESCs. *P* values (two-sided *t* test) are shown. **e** Boxplots showing the DNA methylation change (knockout *(KO)-WT*) for CpG islands (*CGI*) and non-CpG island (*non-CGI*) regions within Polycomb DMVs. *P* value (two-sided *t* test) is shown. **f** Boxplot showing DNA methylation level in Polycomb DMVs for regions with different CG densities in WT and *Eed* ^-/-^ mESC lines

DMVs are insulated self-interacting domains {#Sec7}
-------------------------------------------

It remains unclear how the loss of Polycomb leads to increased DNA methylation in H3K27me3-marked DMVs. DNMTs can be recruited to transcribed gene bodies through H3K36me3 \[[@CR47]--[@CR49]\], raising the question of whether the elevated DNA methylation may result from derepression of developmental genes in the absence of Polycomb. RNA-seq analyses revealed that developmental genes generally showed no or only weak reactivation upon *Eed* knockout in our data (Fig. [4b](#Fig4){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S4D), as also shown in a previous study \[[@CR50]\]. This is true for both genes with DMVs that show hypermethylation and those that remain unmethylated (Additional file [1](#MOESM1){ref-type="media"}: Figure S4E). In addition, we did not observe acquisition of H3K36me3 \[[@CR51]\] in DMVs in *Eed* ^-/-^ cells (Fig. [4c](#Fig4){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S4F), suggesting that the increased DNA methylation is likely not due to increased transcription or H3K36me3. On the other hand, the PRC1 complex can compact chromatin both in vivo and in vitro \[[@CR52], [@CR53]\]. Furthermore, EED also interacts with histone deacetylases \[[@CR54]\], and loss of *Eed* leads to increased histone acetylation \[[@CR55]--[@CR57]\] (Fig. [4c](#Fig4){ref-type="fig"}). It is possible that the loss of *Eed* may lead to decompacted chromatin that allows the access of DNA methyltransferases to Polycomb-targeted DMVs. To determine if this is the case, we performed circular chromosome conformation capture sequencing (4C-seq) to investigate the chromatin architecture around DMV regions in mESCs and *Eed* ^-/-^ cells. Interestingly, for two DMVs we examined (*Pax6* and *Nkx2-2,* where large numbers of restriction enzyme cutting sites are available), the bait regions within the DMVs show strong interactions with other regions inside DMVs, but not regions outside of DMVs (Additional file [1](#MOESM1){ref-type="media"}: Figure S5A). Conversely, regions outside of DMVs demonstrate strong interactions with nearby regions but not those within DMVs. Similar observations were made for two additional DMVs, *Skor1* and *Ebf3* (data not shown). This is consistent with a recent study using 5C-seq published as this manuscript was in preparation \[[@CR58]\]. Interestingly, the local insulated structure can still be observed around *Pax6* and *Nkx2-2* upon the loss of *Eed* in mESCs as determined through 4C-seq (Additional file [1](#MOESM1){ref-type="media"}: Figure S5A). As a control, expected interaction changes were observed at the HoxB region between WT and *Eed* knockout (KO) mESCs \[[@CR59]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S5B). The interactions between DMVs and other Polycomb targets over distance are also lost in *Eed* KO mESCs (Additional file [1](#MOESM1){ref-type="media"}: Figure S5A) as reported previously \[[@CR59]--[@CR62]\]. Notably, Kundu et al. also showed that, upon the loss of *Phc1* (a component of the PRC1 complex) in mESCs, the compaction domains at Polycomb targets are strongly affected at the *Hox* loci, but to a much lesser extent at the *Pax6* locus \[[@CR58]\]. The change of chromatin structure at *Pax6* became much more pronounced when cells underwent differentiation or when *Ring1b* (a key component of PRC1) was absent \[[@CR58]\]. It is possible that the moderate structure changes for DMVs were not captured by 4C-seq due to the limited sensitivity. Therefore, these data indicate that Polycomb regulates DMV domains in a locus-specific and complex-specific manner. Taken together, these results showed that developmental genes and their putative regulatory elements form close interactions within DMVs prior to gene activation. Yet, this self-interacting structure is not entirely dependent on PRC2, at least in undifferentiated mESCs.

Polycomb likely maintains hypomethylation of DMVs through TETs {#Sec8}
--------------------------------------------------------------

On the other hand, it was reported that TETs regulate demethylation of DMVs and promote cell differentiation \[[@CR32], [@CR63], [@CR64]\]. Moreover, TET1 and PRC2 can form a complex \[[@CR65]\]. TET1 can facilitate recruitment of Polycomb \[[@CR66]\], and PRC2 knockdown also leads to downregulation of 5-hydroxymethylcytosine (5hmC) \[[@CR65]\]. Therefore, we asked if Polycomb may regulate DMVs through TET proteins. By analyzing the methylome of *Tet1/2/3* triple KO *(Tet* TKO) mESCs \[[@CR67]\], we found that Polycomb-bound DMVs preferentially show an increase of DNA methylation compared to other DMVs after the loss of TETs, which is very similar to the result when *Eed* is absent (Additional file [1](#MOESM1){ref-type="media"}: Figure S6A). The methylated regions are also limited to non-CGI regions in *Tet* TKO cells (Additional file [1](#MOESM1){ref-type="media"}: Figure S6B). To examine if Polycomb regulates DNA methylation in a similar or distinct pathway compared to TETs, we generated *Tet* TKO and further *Tet*/*Eed* quadruple KO (*Tet*/*Eed* QKO) mESC lines. Knockout of *Tets* and *Eed* was validated by genotyping (data not shown) and the absence of 5hmC and H3K27me3, respectively, in these cells (Additional file [1](#MOESM1){ref-type="media"}: Figure S6C, D). Interestingly, we observed a similar DNA methylation increase in *Tet* TKO and *Tet*/*Eed* QKO cells (Fig. [5a](#Fig5){ref-type="fig"}). Polycomb DMVs preferentially show an increase of DNA methylation in *Tet*/*Eed* QKO cells (Fig. [5b](#Fig5){ref-type="fig"}), with the increased DNA methylation primarily found in regions of low CG density (Fig. [5c](#Fig5){ref-type="fig"}) outside of CGIs (Fig. [5d](#Fig5){ref-type="fig"}). Importantly, DNA methylation in DMV did not show further increase after the loss of EED in *Tet* TKO cells, suggesting that Polycomb may regulate DMVs in the same pathway as TETs. Thus, these data indicate that Polycomb likely regulates DNA methylation in DMVs through TETs.Fig. 5Polycomb likely regulates hypomethylation of DMVs through TETs. **a** UCSC Genome Browser snapshots of DNA methylation near DMV genes *Six3* and *Gata6* in WT, *Tet* TKO, and *Tet*/*Eed* QKO mESCs. Regions with elevated DNA methylation are *shaded. Tet* TKO: *Tet1/2/3* triple knockout, *Tet*/*Eed* QKO: *Tet1/2/3/Eed* quadruple knockout. **b** Boxplots showing the DNA methylation change (KO-WT) of Polycomb DMVs and other DMVs. *P* values (two-sided *t* test) are shown. **c** Boxplots showing DNA methylation level for regions within Polycomb DMVs with different CG densities in WT, *Eed KO*, *Tet* TKO, and *Tet/Eed* QKO mESC lines. **d** Boxplots showing the DNA methylation change (KO-WT) of CpG islands and non-CpG island regions within Polycomb DMVs. *P* values (two-sided *t* test) are shown

Discussion {#Sec9}
==========

The developmental programs are controlled by both transcription factors and epigenetic regulators. DNMTs and Polycomb are two key epigenetic regulators that maintain the silencing of lineage-specifiers \[[@CR6]\]. Our previous work found that these two pathways primarily regulate distinct sets of genes \[[@CR14]\]. Particularly, promoters of developmental genes are preferentially marked by H3K27me3, but they largely maintain hypomethylated DNA over long distances, forming DNA methylation valleys (DMVs). By contrast, DNA methylation is dynamically regulated at the promoters of a small subset of pluripotency genes and genes restricted in terminally differentiated tissues \[[@CR14]\]. How DMVs are maintained methylation-free is not fully understood. In this study, we first showed that DMVs are hotspots of transcription factor binding and demonstrate high sequence fidelity during evolution. DMVs also display a distinct chromatin structure by forming insulated and self-interacting domains. A further systematic analysis of DMVs in mouse tissues showed that while the majority of DMVs remain constantly hypomethylated, a subset of them, especially those large DMVs, are dynamically regulated. The first class of dynamic DMVs are preferentially marked by super-enhancers, and their hypomethylation is likely associated with dense binding of transcription factors \[[@CR44]\]. The second class, on the other hand, is preferentially marked by strong enrichment of H3K27me3. Surprisingly, the second class shows loss of H3K27me3 but elevated DNA methylation when nearby genes are expressed. Consistently, *Eed* knockout in mESCs also leads to elevated DNA methylation in DMVs, supporting a role of Polycomb in maintaining the hypomethylation of DMVs (Fig. [6](#Fig6){ref-type="fig"}). This likely reinforces the antagonism between Polycomb and DNA methylation, given that DNA methylation also restricts H3K27me3 to promoters \[[@CR23], [@CR24], [@CR68]\]. Upon DNA methylation depletion, H3K27me3 would spread to other regions, leading to decrease of H3K27me3 at development gene promoters. Our data also showed that this is likely true for EED as well (Additional file [1](#MOESM1){ref-type="media"}: Figure S6E). This antagonism may ensure the proper division of epigenetic regulators in their targets in the genome.Fig. 6A model for the role of Polycomb in maintenance of DMV hypomethylation. Polycomb-targeted DMVs have lower nucleosome occupancy and higher CG density than their surrounding regions. They tend to form insulated structures from their surrounding methylated regions. In WT mESCs, Polycomb maintains DMV hypomethylation in non-CGI regions, likely through recruiting TETs. The absence of Polycomb leads to increase of DNA methylation in non-CGI regions and also increase of H3K27ac in CGI regions \[[@CR56]\]. Genes near DMVs remain silenced during this process. CGIs in DMVs are maintained DNA methylation-free, presumably due to additional protection mechanisms including H3K4me3

How does Polycomb prevent DNA methylation in DMVs? Interestingly, we found that there exist regions in mESCs that are occupied by H3K27me3 but not Polycomb. These regions are still hypermethylated, suggesting that Polycomb, but not H3K27me3, is more likely to be involved in hypomethylation of DMVs. This is consistent with the previous studies showing that DNA methylation and H3K27me3 can indeed co-exist, particularly in regions with low CG densities \[[@CR23], [@CR27]\]. Polycomb can compact chromatin both in vitro and in vivo \[[@CR52], [@CR57], [@CR58]\], raising an interesting question: Does Polycomb-mediated chromatin compaction possibly restrict the entrance of DNA methyltransferases? Indeed, DMV domains were shown to be more accessible in cells deficient in various Polycomb complex components in a perhaps locus-dependent manner \[[@CR58]\]. This model, however, would presumably allow entrance of both DNMTs and TETs to DMVs. On the other hand, TET proteins were shown to be involved in demethylating DMVs \[[@CR18], [@CR32], [@CR63], [@CR65]\]. TET1 and PRC2 can form a complex, and their functions are interdependent \[[@CR65], [@CR66]\]. Our data further showed that loss of *Eed*, *Tet,* or both results in a similar increase of DNA methylation of DMVs, suggesting that Polycomb may regulate hypomethylation of DMVs through TET proteins (Fig. [6](#Fig6){ref-type="fig"}).

What are the functions of DMVs at developmental genes? Developmental genes tend to be regulated by a large number of transcription factors, which preferentially bind DMVs near these genes (Fig. [2a, b](#Fig2){ref-type="fig"}). DMVs often include both CpG island regions and non-CpG island regions. While CpG island regions are known to resist DNA methylation \[[@CR19]\], non-CpG island regions in the genome are prone to DNA methylation. Exposing these TF binding sites to DNA methylation may possibly restrict the plasticity of gene expression in development. Alternatively, hypomethylation may reduce the risks of spontaneous deamination mutations caused by DNA methylation. Interestingly, a hallmark of cancer cells is aberrant promoter DNA methylation at developmental genes and Polycomb targets \[[@CR69]--[@CR72]\]. In line with this, many DMVs are preferentially marked by DNA methylation instead of H3K27me3 in cancer \[[@CR14]\]. Curiously, the switch of repressive mechanisms occurs even though these genes are frequently silenced in both normal and cancer cells \[[@CR73]\]. It is tempting to speculate that that this change of repression mechanism may be associated with increased mutation rates. Consistently, the C-to-T mutation is the most frequent mutation in cancer \[[@CR40]\]. Both H3K4 and H3K27 methyltransferases are frequently dysregulated in cancer \[[@CR74], [@CR75]\]. Notably, developmental transcription factors including HOX genes are known to retain significantly higher portions of CGs in their coding regions compared to the genome average \[[@CR76]\]. This, however, is not observed in organisms with no or a very low level of DNA methylation, such as drosophila. The unmethylated CpG islands may further help recruit Polycomb, which in turn promotes hypomethylation of DMVs, therefore creating a positive feedback loop. Finally, it is worth noting that Polycomb and TETs are only partially responsible for keeping DMV methylation-free. Future studies are needed to identify additional regulators that safeguard DMVs and, in particular, the high-CG regions that they contain. Taken together, our results revealed a possible role of Polycomb in the hypomethylation of DMVs at key developmental genes to maintain developmental plasticity and sequence fidelity of regulatory elements.

Conclusions {#Sec10}
===========

One key question in epigenetics and development is: What is the exact role of DNA methylation in silencing lineage regulators? Despite the widespread presence of DNA methylation in the genome, the majority of developmental genes are in fact present in large constitutively hypomethylated regions, or DNA methylation valleys (DMVs). Here, we showed that DMVs are hotspots of transcription factor bindings and are highly conserved across vertebrates. Our 4C-seq data revealed that DMVs are insulated and self-interacting domains, indicating that developmental genes and their regulatory elements are restricted in local territory away from neighbor regions. Finally, we showed that Polycomb regulates DNA methylation in DMVs likely by recruiting the TET proteins. Our study not only highlights the important role of Polycomb in maintaining DNA methylation-free at regulatory elements of developmental genes, but it also unveils the mechanisms for the functional divisions of epigenetic regulators in controlling lineage specification.

Methods {#Sec11}
=======

Generation of knockout mESC lines {#Sec12}
---------------------------------

*Tet* TKO cells (R1) and *Tet*/*Eed* QKO (R1) were generated using CRISPR/Cas9. All single guide RNAs (sgRNAs) were designed using an online tool (<http://crispr.mit.edu/>) \[[@CR77]\]. *Tet* genes were knocked out using one pair of sgRNAs and *Eed* using two pairs of sgRNAs. The sequences of sgRNAs were included in Table [1](#Tab1){ref-type="table"}. The plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9-PuroR (modified from pX330) \[[@CR77]\] co-expressing Cas9 and sgRNA was used to transfect cells. Each pair of sgRNAs was phosphorylated, annealed, and ligated to a linearized vector. mESCs were transfected using plasmids with sgRNAs in Lipofectamine 3000 (L3000008, Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer's instructions. Puromycin with a final concentration of 1 μg/mL was added to screen the transfected cells. After 24-h selection, about 50 cells were separated into a 96-well dish and cultured for about 1 week. Single clones were picked out and lysed with buffer K (36 μL ddH2O + 4 μL 10 × TBS + 0.4 μL 50% Tween 20 + 0.2 μL protease K) at 56 °C for 45 min and 95 °C for 15 min before genotyping.

The sgRNA targeted regions were as follows:*Tet1* chr10:62296286-62296377*Tet2* chr3:133148483-133151645*Tet3* chr6:83352674-83354788*Eed* chr7:97118816-97120844

Cell culture {#Sec13}
------------

All mESCs were passaged every 48--72 h in Dulbecco's modified Eagle's medium (DMEM, Gibco) supplemented with 15% fetal bovine serum (FBS, HyClone), 1% non-essential amino acids (Gibco), 0.5% 2-mercaptoethanol (Gibco), 1% penicillin/streptomycin (Millipore, Bedford, MA, USA), 0.01% leukemia inhibiting factor (LIF) (Millipore), and 1% glutamine (Gibco) on gelatinized plates.

MethylC-seq library generation and sequencing {#Sec14}
---------------------------------------------

We mixed 5 μg of genomic DNA isolated from mESCs with 25 ng unmethylated cl857Sam7 Lambda DNA (D1521, Promega, Madison, WI, USA). The DNA was fragmented by sonication to 100--600 bp with a Branson 450 Sonifier (Branson), followed by end repair with the End-It DNA End-Repair Kit (ER072, Epicentre). Paired-end cytosine-methylated adapters were ligated to the sonicated DNA for genomic DNA library construction. Adapter-ligated DNA of 200--400 bp was isolated by 2% agarose gel electrophoresis, and sodium bisulfite conversion was performed on it using the EZ DNA Methylation-Gold Kit (D5006, Zymo Research, Irvine, CA, USA) as per the manufacturer's instructions. Half of the bisulfite-converted, adapter-ligated DNA molecules were enriched by 10 cycles of polymerase chain reaction (PCR) with the following reaction composition: 2.5 U of uracil-insensitive Pfu Turbo Cx Hotstart DNA Polymerase (600410, Stratagene), 5 μL 10× Pfu Turbo Reaction Buffer (600410, Stratagene), 25 mM deoxynucleotides (dNTPs), 0.5 μM TruSeq primer 1, and 0.5 μM TruSeq primer 2 (final volume 50 μL). The reaction products were purified using the MinElute PCR Purification Kit (28006, Qiagen, Hilden, Germany), separated by 2% agarose gel electrophoresis, and purified using the MinElute Gel Extraction Kit (28606, Qiagen). The bisulfite conversion rate was calculated as the percentage of cytosines sequenced at cytosine reference positions in the lambda genome. Libraries were sequenced on an Illumina HiSeq instrument (Illumina, San Diego, CA, USA) per the manufacturer's instructions.

ChIP-seq library generation and sequencing {#Sec15}
------------------------------------------

ChIP was carried out as previously described with 20 μg chromatin (500 μg for EED) and 5 μg antibody with the following antibodies: EED (61203, Active Motif, Carlsbad, CA, USA), H3K4me3 (04-745, Millipore), H3K27ac (39133, Active Motif), and H3K27me3 (39155, Active Motif). ChIP and input library preparation and sequencing procedures were carried out as described previously \[[@CR78]\].

RNA-seq library generation and sequencing {#Sec16}
-----------------------------------------

Total RNA from WT and *Eed* ^-/-^ mESCs were extracted using Trizol (15596026, Ambion) according to the manufacturer's instructions. We treated 10 μg RNA with DNase I (EN0521, Fermentas) at 37 °C for 1 h to remove DNA. Ribosomal RNA was removed using a Ribo-Zero Magnetic Gold Kit (MRZ11124C, Epicentre). Purified RNA was fragmented with RNA Fragmentation Buffer (E6186A, New England Biolabs (NEB), Ipswich, MA, USA) at 95 °C for 5 min and stopped with ethylenediaminetetraacetic acid (EDTA). The strand-specific RNA libraries were prepared as described previously \[[@CR79]\] and sequenced on an Illumina HiSeq instrument per the manufacturer's instructions.

4C-seq library generation and sequencing {#Sec17}
----------------------------------------

Cells were crosslinked with 1% formaldehyde at room temperature for 10 min, then treated with 0.14 M glycine for 15 min. The crosslinked cells were incubated in lysis buffer (5 mM Tris at pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1% TritonX-100, and fresh proteinase inhibitor) for 1 h. After being centrifuged at 3000 rpm for 5 min, the supernatants were removed. The cell pellets were resuspended in 1× NEB buffer 2 with 50 U *Hin*dIII (NEB) and digested at 37 °C overnight. The digested samples were ligated in 1× T4 DNA ligase buffer with 2000 U T4 DNA ligase (NEB) at 24 °C for 6 h. The ligated products were treated with 5 μL Proteinase K (20 mg/mL) at 55 °C for 30 min, then incubated at 65 °C overnight. After reversing the crosslinking, the DNA was purified by phenol-chloroform extraction and precipitated with EtOH. The prepared DNA as a 3C library was used for 4C.

The 4C experiments were performed as described previously \[[@CR80]\] with minor changes. Briefly, the 3C library was digested with 50 U Dpn II (NEB) at 37 °C overnight and ligated with 4000 U T4 DNA ligase (NEB) at 4 °C for 16 h. The DNA was purified by phenol-chloroform extraction and precipitated with EtOH. For each 4C library 200 ng of DNA was amplified with specific inverse primers using the Expand Long Range PCR System (Roche). First, 1.5 μM each of the short primers without TruSeq adapters were used to amplify the 4C libraries in a 25-μL reaction volume under the following program: 94 °C, 2 min; 10 cycles × (94 °C, 30 s; 55 °C, 1 min; 68 °C, 1 min); 68 °C, 7 min. PCR products were purified with AMPure beads to recover the DNA fragments of size 100---500 bp. The purified DNA products were amplified by the long primer pairs with the specific TruSeq adapters in a 50-μL volume as follows: 94 °C, 2 min; (94 °C, 30 s; 55 °C, 1 min; 68 °C, 1 min) × 10 cycles; 68 °C, 7 min; (94 °C, 30 s; 68 °C, 1 min + 20s/additional cycles; 68 °C, 1 min) × 15 cycles; 68 °C, 7 min. The final PCR products purified with AMPure beads were sequenced on an Illumina HiSeq instrument per the manufacturer's instructions. The primers used in this study are listed in Table [1](#Tab1){ref-type="table"}.Table 1Primers/oligos used in this study*Tet1* sgRNA-FCACCggctgctgtcagggagctca*Tet1* sgRNA-RAAACtgagctccctgacagcagcc*Tet2* sgRNA-FCACCgaaagtgccaacagatatcc*Tet2* sgRNA-RAAACggatatctgttggcactttc*Tet3* sgRNA-FCACCgagtgccccgacttcctcgag*Tet3* sgRNA-RAAACctcgaggaagtcggggcactc*Eed* sgRNA 1-FCACCgaggtgctgccgccttgtttt*Eed* sgRNA 1-RAAACaaaacaaggcggcagcacctc*Eed* sgRNA 2-FCACCgctacttttgaattcacatc*Eed* sgRNA 2-RAAACgatgtgaattcaaaagtagc4C bait in DMV *Pax6*-F without adapterstcagtgggagaggccactgg4C bait in DMV *Pax6*-R without adaptersccccacagtccatctctcag4C bait in DMV *Pax6*-F with adaptersAatgatacggcgaccaccgagatctacactctttccctacacgacg ctcttccgatcttcagtgggagaggccactgg4C bait in DMV *Pax6*-R with adaptersCaagcagaagacggcatacgagatcaggatgtgactggagttcag acgtgtgctcttccg4C bait out of DMV *Pax6*-F without adaptersaacagacattctttgccact4C bait out of DMV *Pax6*-R without adaptersacatttggaggccacagatc4C bait out of DMV *Pax6*-F with adaptersaatgatacggcgaccaccgagatctacactctttccctacacgacgctcttccgatctaacagacattctttgccact4C bait out of DMV *Pax6*-R with adapterscaagcagaagacggcatacgagattgtggcgtgactggagttcagacgtgtgctcttccg4C bait in DMV *Nkx2-2*-F without adapterstccacgcagaattctttagt4C bait in DMV *Nkx2-2*-R without adapterstatctccagctgtgcctgt4C bait in DMV *Nkx2-2*-F with adaptersaatgatacggcgaccaccgagatctacactctttccctacacgacgctcttccgatcttccacgcagaattctttagt4C bait in DMV *Nkx2-2*-R with adapterscaagcagaagacggcatacgagattacgacgtgactggagttcagacgtgtgctcttccg4C bait out of DMV *Nkx2-2-*F without adaptersgcctaggcactggaaaactg4C bait out of DMV *Nkx2-2*-R without adaptersagaccaggactcacaccaca4C bait out of DMV *Nkx2-2*-F with adaptersaatgatacggcgaccaccgagatctacactctttccctacacgacgctcttccgatctgcctaggcactggaaaactg4C bait out of DMV *Nkx2-2*-R with adapterscaagcagaagacggcatacgagatacagacgtgactggagttcagacgtgtgctcttcc

Western blot {#Sec18}
------------

Histone extracts were run on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred to a nitrocellulose membrane. The nitrocellulose membrane was blocked with 5% milk for 1 h and incubated with antibodies against H3K27me3 (39155, Active Motif), H3K4me3 (04-745, Millipore), or α-tubulin (BE0026, EasyBio) at 4 °C overnight. On the second day, the membrane was incubated with secondary antibody at room temperature for 1 h. Chemiluminescent detection was done using SuperSignal^TM^ West Dura Extended Duration Substrate (34076, Thermo Fisher).

5hmC dot blot {#Sec19}
-------------

DNA samples were diluted to different concentration gradients and denatured with 0.4 M NaOH and 10 mM EDTA at 99 °C for 10 min. The denatured DNA was cooled on ice immediately and loaded to a nylon transfer membrane (RNP303B, GE) followed by UV crosslinking. The membrane was dried and blocked in 10% milk for 1 h. 5hmC antibody (39769, Active Motif) was 1:2000 diluted in 10% milk and incubated with the membrane at room temperature for 2 h. After being washed with Tris-buffered saline Tween 20 (TBST) five times, the membrane was incubated with secondary antibody at room temperature for 1 h. Chemiluminescent detection was done by SuperSignal West Dura Extended Duration Substrate (34076, Thermo).

Data analyses {#Sec20}
-------------

### ChIP-seq data processing {#Sec21}

For WT and *Eed* ^-/-^ mESCs, ChIP-seq reads were aligned to mm9 with Bowtie2 (version 2.2.2) with parameters -t -q -N 1 -L 25. All unmapped reads, multi-mapped reads, and PCR duplicates were removed. To generate the ChIP-seq signals for each histone modification shown in the University of California, Santa Cruz (UCSC) Genome Browser, we normalized the read counts by computing the number of reads per kilobase of bin per million reads sequenced (RPKM). To minimize the batch and cell type variation, the RPKM values were further normalized through Z-score transformation, by subtracting the mean of RPKM across the genome and dividing by the standard deviation of RPKM across the genome.

### MethylC-seq data processing {#Sec22}

For WT and mutant mESCs, MethylC-seq reads were aligned to mm9 using the Bisulfite Sequence Mapping Program (BSMAP) \[[@CR81]\] with parameters --r 0 --w 100 --v 0.1 --A AGATCGGAAGAGC. Multi-mapped reads and PCR duplicates were removed. After mapping, those 200-bp bins with total CG coverage less than 5 were removed. Methylation level was calculated using methylated CpG versus total CpG in each bin.

### RNA-seq data processing {#Sec23}

For WT and *Eed* ^-/-^ mESCs, the RNA-seq reads were mapped to mm9 with TopHat (version 1.20). The mapped reads were further analyzed by Cufflinks \[[@CR82]\], and the expression levels for each transcript were quantified as fragments per kilobase of transcript per million mapped reads (FPKM).

### 4C-seq data processing {#Sec24}

Reads with the 5' end mapped to a 4C forward primer were selected from the total fastq file. The selected reads were mapped to the mm9 assembly with Bowtie2 (version 2.2.2). The mapped reads were further mapped to *Hin*dIII sites with the software fourSig \[[@CR83]\]. The fragment counts were finally normalized per one million reads.

Identification and classification of DMVs {#Sec25}
-----------------------------------------

DMVs were identified as previously described \[[@CR14]\]. Briefly, the genome was first divided into 1-kb bins, and the DNA methylation level was averaged within each bin. Then a sliding 5-kb window (with 1-kb steps) was used to identify regions that have an averaged methylation level less than 0.15 in a 5-kb window. Continuous regions resulting from this analysis were then merged to form DMVs. Dynamic DMVs were defined as follows: all tsDMRs previously identified \[[@CR15]\] with length over 2 kb were used in this analysis. DMVs with at least one entire tsDMR, or DMVs with more than half of the regions covered by tsDMRs, were defined as dynamic DMVs. Other DMVs were considered as constant DMVs (group I). Two additional groups of DMVs were identified from dynamic DMVs by analyzing the correlation between the changes of DNA methylation and transcription activities of nearby genes. Given DMVs frequently show similar patterns within each of the four lineages (blood, endoderm, mesoderm, and ectoderm as defined in \[[@CR15]\]); we simplified the analysis by combining data from the same lineage. Specifically, for each DMV and related gene, the average DNA methylation levels and expression levels (FPKM) were computed for each of the four lineages (blood, endoderm, mesoderm, and ectoderm) \[[@CR15]\]. We first identified dynamically regulated genes associated with DMVs. For a dynamically expressed gene, the FPKM in one lineage (highest among four lineages, with a minimal FPKM of 2) is three times more than the average FPKM in the other three lineages (with a maximal average FPKM of 2). For these dynamically expressed DMV genes, if we observed a negative correlation between expression and DNA methylation among the four lineages, the DMVs were clustered to group II. On the contrary, if we observed a positive correlation between expression and DNA methylation, those DMVs were clustered to group III.
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